Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Viventia enhances phase I bladder cancer program for Proxinium

Nov. 22, 2004

Restructuring at Tapestry

Nov. 22, 2004

Efaproxiral improves survival after WBRT in patients with brain metastasis

Nov. 19, 2004

Antitumor effects and safety profile of LEP-ETU in advanced cancer

Nov. 19, 2004

Novel series of VEGFR/KDR inhibitors covered by Amgen patent

Nov. 19, 2004

Lilly advances Isis collaborative compound into phase I

Nov. 19, 2004

Update on the antitumor effects and safety of lapatinib in advanced breast cancer

Nov. 18, 2004

Protein kinase modulators claimed by Exelixis

Nov. 18, 2004

Vertex patent covers protein kinase inhibitors

Nov. 18, 2004

Doxorubicin Transdrug receives European orphan drug status

Nov. 18, 2004

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...